ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
Revenue ScalingExpanding
Percentile Rank64
3Y CAGR+18.1%
5Y CAGR+13.8%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+18.1%/yr
vs -4.9%/yr prior
5Y CAGR
+13.8%/yr
Recent acceleration
Acceleration
+23.0pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$9.22B+12.6%
2024$8.19B+23.0%
2023$6.66B+19.0%
2022$5.60B+24.3%
2021$4.50B-7.0%
2020$4.84B-19.4%
2019$6.00B-12.2%
2018$6.83B-14.3%
2017$7.97B-7.3%
2016$8.59B-